EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Pharma-Bio Serv Inc. (PBSV) had EBIT Margin of -15.99% for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
$1.96M |
|
$-0.20M |
|
$1.39M |
|
$0.57M |
|
$2.28M |
|
$-0.31M |
|
$0.10M |
|
$-0.21M |
|
$-0.21M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
$-0.31M |
|
$-0.26M |
|
22.93M |
|
22.94M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$13.16M |
|
$0.13M |
|
$0.43M |
|
$13.59M |
|
$1.66M |
|
-- |
|
-- |
|
$1.66M |
|
$11.93M |
|
$11.93M |
|
$11.93M |
|
22.92M |
|
| Cash Flow Statement Financials | |
$-0.49M |
|
$-0.61M |
|
$-1.74M |
|
$6.77M |
|
$3.96M |
|
$-2.81M |
|
$0.03M |
|
$-1.72M |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.25% |
|
-15.99% |
|
|
EBIT Margin |
-15.99% |
-- |
|
-10.65% |
|
-10.40% |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
0.97 |
|
92.40 |
|
-1.71% |
|
-1.71% |
|
-1.50% |
|
-1.71% |
|
$0.52 |
|
$-0.02 |
|
$-0.02 |
|